{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:20:37Z","timestamp":1776424837873,"version":"3.51.2"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004883","name":"Shahrekord University","doi-asserted-by":"publisher","award":["No. 141.349"],"award-info":[{"award-number":["No. 141.349"]}],"id":[{"id":"10.13039\/501100004883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11668-3","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:19:13Z","timestamp":1776421153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical, immunohistochemical, and pathological assessment of a mouse model of experimental autoimmune encephalomyelitis induced by a eukaryotic RpfE\u2013MOG(35\u201355)-expressing plasmid"],"prefix":"10.1007","volume":"53","author":[{"given":"Maryam","family":"Ziaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Aliomrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moosa","family":"Javdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Shakhsi-Niaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"11668_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15:545\u2013558. https:\/\/doi.org\/10.1038\/nri3871","journal-title":"Nat Rev Immunol"},{"key":"11668_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12640-021-00361-x","volume":"39","author":"T Danesh-Seta","year":"2021","unstructured":"Danesh-Seta T, Emami F, Nasr-Esfahani MH et al (2021) Bee Venom\u2013Derived BBB Shuttle and its Correlation with Oligodendrocyte Proliferation Markers in Mice Model of Multiple Sclerosis. Neurotox Res 39:1181\u20131188. https:\/\/doi.org\/10.1007\/s12640-021-00361-x","journal-title":"Neurotox Res"},{"key":"11668_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jneumeth.2017.04.003","volume":"284","author":"JPC Hasselmann","year":"2017","unstructured":"Hasselmann JPC, Karim H, Khalaj AJ et al (2017) Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL\/6 mice for the longitudinal study of pathology and repair. J Neurosci Methods 284:71\u201384. https:\/\/doi.org\/10.1016\/j.jneumeth.2017.04.003","journal-title":"J Neurosci Methods"},{"key":"11668_CR4","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1182\/blood-2007-09-113050","volume":"111","author":"CS Hinrichs","year":"2008","unstructured":"Hinrichs CS, Spolski R, Paulos CM et al (2008) IL-2 and IL-21 confer opposing differentiation programs to CD8\u2009+\u2009T cells for adoptive immunotherapy. Blood 111:5326\u20135333. https:\/\/doi.org\/10.1182\/blood-2007-09-113050","journal-title":"Blood"},{"key":"11668_CR5","doi-asserted-by":"publisher","unstructured":"Voskuhl RR, MacKenzie-Graham A (2022) Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis. Front Mol Neurosci 15. https:\/\/doi.org\/10.3389\/fnmol.2022.1024058","DOI":"10.3389\/fnmol.2022.1024058"},{"key":"11668_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmed.2010.11.006","volume":"17","author":"BA \u2019t Hart","year":"2011","unstructured":"\u2019t Hart BA, Gran B, Weissert R (2011) EAE: Imperfect but useful models of multiple sclerosis. Trends Mol Med 17:119\u2013125. https:\/\/doi.org\/10.1016\/j.molmed.2010.11.006","journal-title":"Trends Mol Med"},{"key":"11668_CR7","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.vaccine.2010.08.103","volume":"29","author":"JE Libbey","year":"2011","unstructured":"Libbey JE, Fujinami RS (2011) Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine 29:3356\u20133362. https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.103","journal-title":"Vaccine"},{"key":"11668_CR8","doi-asserted-by":"publisher","unstructured":"Miller SD, Karpus WJ, Davidson TS (2010) Experimental Autoimmune Encephalomyelitis in the Mouse. Curr Protoc Immunol 88. https:\/\/doi.org\/10.1002\/0471142735.im1501s88","DOI":"10.1002\/0471142735.im1501s88"},{"key":"11668_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","volume":"759","author":"C Procaccini","year":"2015","unstructured":"Procaccini C, De Rosa V, Pucino V et al (2015) Animal models of Multiple Sclerosis. Eur J Pharmacol 759:182\u2013191. https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.042","journal-title":"Eur J Pharmacol"},{"key":"11668_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/20477724.2017.1351080","volume":"111","author":"M Faridgohar","year":"2017","unstructured":"Faridgohar M, Nikoueinejad H (2017) New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection. Pathog Glob Health 111:256\u2013264. https:\/\/doi.org\/10.1080\/20477724.2017.1351080","journal-title":"Pathog Glob Health"},{"key":"11668_CR11","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/eji.201445329","volume":"45","author":"H Choi","year":"2015","unstructured":"Choi H, Kim WS, Back YW et al (2015) Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17\u2010type T\u2010cell immunity via TLR4\u2010dependent maturation of dendritic cells. Eur J Immunol 45:1957\u20131971. https:\/\/doi.org\/10.1002\/eji.201445329","journal-title":"Eur J Immunol"},{"key":"11668_CR12","doi-asserted-by":"publisher","first-page":"7535","DOI":"10.3390\/ijms22147535","volume":"22","author":"H-S Park","year":"2021","unstructured":"Park H-S, Choi S, Back Y-W et al (2021) Mycobacterium tuberculosis RpfE-Induced Prostaglandin E2 in Dendritic Cells Induces Th1\/Th17 Cell Differentiation. Int J Mol Sci 22:7535. https:\/\/doi.org\/10.3390\/ijms22147535","journal-title":"Int J Mol Sci"},{"key":"11668_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1674-8301(12)60003-7","volume":"26","author":"Y Xue","year":"2012","unstructured":"Xue Y, Bai Y, Gao X et al (2012) Expression, purification and characterization of Mycobacterium tuberculosis RpfE protein. J Biomed Res 26:17\u201323. https:\/\/doi.org\/10.1016\/S1674-8301(12)60003-7","journal-title":"J Biomed Res"},{"key":"11668_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0165-5728(92)90016-E","volume":"38","author":"BL McRae","year":"1992","unstructured":"McRae BL, Kennedy MK, Tan L-J et al (1992) Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J Neuroimmunol 38:229\u2013240. https:\/\/doi.org\/10.1016\/0165-5728(92)90016-E","journal-title":"J Neuroimmunol"},{"key":"11668_CR15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164:1079\u20131106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x","journal-title":"Br J Pharmacol"},{"key":"11668_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clim.2010.11.011","volume":"142","author":"N Fissolo","year":"2012","unstructured":"Fissolo N, Montalban X, Comabella M (2012) DNA-based vaccines for multiple sclerosis: Current status and future directions. Clin Immunol 142:76\u201383. https:\/\/doi.org\/10.1016\/j.clim.2010.11.011","journal-title":"Clin Immunol"},{"key":"11668_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-9-139","volume":"9","author":"N Fissolo","year":"2012","unstructured":"Fissolo N, Costa C, Nurtdinov RN et al (2012) Treatment with MOG-DNA vaccines induces CD4\u2009+\u2009CD25+FoxP3\u2009+\u2009regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis. J Neuroinflamm 9:1\u201313. https:\/\/doi.org\/10.1186\/1742-2094-9-139","journal-title":"J Neuroinflamm"},{"key":"11668_CR18","doi-asserted-by":"publisher","unstructured":"Mannie MD, Blanchfield JL, Islam SMT, Abbott DJ (2012) Cytokine-Neuroantigen Fusion Proteins as a New Class of Tolerogenic, Therapeutic Vaccines for Treatment of Inflammatory Demyelinating Disease in Rodent Models of Multiple Sclerosis. Front Immunol 3. https:\/\/doi.org\/10.3389\/fimmu.2012.00255","DOI":"10.3389\/fimmu.2012.00255"},{"key":"11668_CR19","unstructured":"UniProt https:\/\/www.uniprot.org\/"},{"key":"11668_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0116878","volume":"10","author":"R Haryadi","year":"2015","unstructured":"Haryadi R, Ho S, Kok YJ et al (2015) Optimization of heavy chain and light chain signal peptides for high level expression of therapeutic antibodies in CHO cells. PLoS ONE 10:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0116878","journal-title":"PLoS ONE"},{"key":"11668_CR21","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen X, Zaro JL, Shen WC (2013) Fusion protein linkers: Property, design and functionality. Adv Drug Deliv Rev 65:1357\u20131369. https:\/\/doi.org\/10.1016\/j.addr.2012.09.039","journal-title":"Adv Drug Deliv Rev"},{"key":"11668_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1742-2094-9-139","volume":"9","author":"N Fissolo","year":"2012","unstructured":"Fissolo N, Costa C, Nurtdinov RN et al (2012) Treatment with MOG-DNA vaccines induces CD4\u2009+\u2009CD25+FoxP3\u2009+\u2009regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis. J Neuroinflamm 9:139. https:\/\/doi.org\/10.1186\/1742-2094-9-139","journal-title":"J Neuroinflamm"},{"key":"11668_CR23","doi-asserted-by":"publisher","unstructured":"Bittner S, Afzali AM, Wiendl H, Meuth SG (2014) Myelin Oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice. J Vis Exp 3\u20137. https:\/\/doi.org\/10.3791\/51275","DOI":"10.3791\/51275"},{"key":"11668_CR24","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1167\/iovs.04-0554","volume":"45","author":"H Shao","year":"2004","unstructured":"Shao H (2004) Myelin\/Oligodendrocyte Glycoprotein-Specific T-Cells Induce Severe Optic Neuritis in the C57Bl\/6 Mouse. Invest Ophthalmol Vis Sci 45:4060\u20134065. https:\/\/doi.org\/10.1167\/iovs.04-0554","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11668_CR25","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1007\/s11033-020-05959-6","volume":"47","author":"S Gholami","year":"2020","unstructured":"Gholami S, Mirian M, Eftekhari SM, Aliomrani M (2020) Apamin administration impact on miR-219 and miR-155-3p expression in cuprizone induced multiple sclerosis model. Mol Biol Rep 47:9013\u20139019. https:\/\/doi.org\/10.1007\/s11033-020-05959-6","journal-title":"Mol Biol Rep"},{"key":"11668_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/1352458506070928","volume":"12","author":"C Laule","year":"2006","unstructured":"Laule C, Leung E, Li DK et al (2006) Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult scler j 12:747\u2013753. https:\/\/doi.org\/10.1177\/1352458506070928","journal-title":"Mult scler j"},{"key":"11668_CR27","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1007\/s12640-021-00412-3","volume":"39","author":"H Fattahi","year":"2021","unstructured":"Fattahi H, Esmaeil N, Aliomrani M (2021) Apamin as a BBB Shuttle and Its Effects on T Cell Population During the Experimental Autoimmune Encephalomyelitis-Induced Model of Multiple Sclerosis. Neurotox Res 39:1880\u20131891. https:\/\/doi.org\/10.1007\/s12640-021-00412-3","journal-title":"Neurotox Res"},{"key":"11668_CR28","doi-asserted-by":"publisher","first-page":"577581","DOI":"10.1016\/j.jneuroim.2021.577581","volume":"356","author":"K Naresh","year":"2021","unstructured":"Naresh K, Miraclin TA, Prabhakar AT et al (2021) Epstein-Barr virus infection in a woman with aquaporin-4 seropositive neuromyelitis optica. J Neuroimmunol 356:577581. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577581","journal-title":"J Neuroimmunol"},{"key":"11668_CR29","doi-asserted-by":"publisher","first-page":"105848","DOI":"10.1016\/j.msard.2024.105848","volume":"90","author":"J Lopes","year":"2024","unstructured":"Lopes J, Fonte J, Costa A et al (2024) Polyautoimmunity and multiple autoimmune syndrome in patients with neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 90:105848. https:\/\/doi.org\/10.1016\/j.msard.2024.105848","journal-title":"Mult Scler Relat Disord"},{"key":"11668_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clim.2010.11.011","volume":"142","author":"N Fissolo","year":"2012","unstructured":"Fissolo N, Montalban X, Comabella M (2012) DNA-based vaccines for multiple sclerosis: Current status and future directions. Clin Immunol 142:76\u201383. https:\/\/doi.org\/10.1016\/j.clim.2010.11.011","journal-title":"Clin Immunol"},{"key":"11668_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/brainsci10060333","volume":"10","author":"O Kammona","year":"2020","unstructured":"Kammona O, Kiparissides C (2020) Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis. Brain Sci 10:333. https:\/\/doi.org\/10.3390\/brainsci10060333","journal-title":"Brain Sci"},{"key":"11668_CR32","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/archneur.64.10.nct70002","volume":"64","author":"A Bar-Or","year":"2007","unstructured":"Bar-Or A, Vollmer T, Antel J et al (2007) Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1\/2 Trial. Arch Neurol 64:1407. https:\/\/doi.org\/10.1001\/archneur.64.10.nct70002","journal-title":"Arch Neurol"},{"key":"11668_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S2221-1691(15)30366-X","volume":"5","author":"SSAA Hasson","year":"2015","unstructured":"Hasson SSAA, Al-Busaidi JKZ, Sallam TA (2015) The past, current and future trends in DNA vaccine immunisations. Asian Pac J Trop Biomed 5:344\u2013353. https:\/\/doi.org\/10.1016\/S2221-1691(15)30366-X","journal-title":"Asian Pac J Trop Biomed"},{"key":"11668_CR34","doi-asserted-by":"publisher","unstructured":"Mannie MD, Blanchfield JL, Islam SMT, Abbott DJ (2012) Cytokine-Neuroantigen Fusion Proteins as a New Class of Tolerogenic, Therapeutic Vaccines for Treatment of Inflammatory Demyelinating Disease in Rodent Models of Multiple Sclerosis. Front Immunol 3. https:\/\/doi.org\/10.3389\/fimmu.2012.00255","DOI":"10.3389\/fimmu.2012.00255"},{"key":"11668_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2172-12-72","volume":"12","author":"DJ Abbott","year":"2011","unstructured":"Abbott DJ, Blanchfield JL, Martinson DA et al (2011) Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE). BMC Immunol 12:72. https:\/\/doi.org\/10.1186\/1471-2172-12-72","journal-title":"BMC Immunol"},{"key":"11668_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2249.2004.02418.x","volume":"136","author":"S Stosic-Grujicic","year":"2004","unstructured":"Stosic-Grujicic S, Ramic Z, Bumbasirevic V et al (2004) Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant. Clin Exp Immunol 136:49\u201355. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02418.x","journal-title":"Clin Exp Immunol"},{"key":"11668_CR37","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/eji.201445329","volume":"45","author":"H-GG Choi","year":"2015","unstructured":"Choi H-GG, Kim WS, Back YW et al (2015) Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells. Eur J Immunol 45:1957\u20131971. https:\/\/doi.org\/10.1002\/eji.201445329","journal-title":"Eur J Immunol"},{"key":"11668_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00430-019-00640-7","volume":"209","author":"B Vakili","year":"2020","unstructured":"Vakili B, Nezafat N, Zare B et al (2020) A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB\/c mice. Med Microbiol Immunol 209:69\u201379. https:\/\/doi.org\/10.1007\/s00430-019-00640-7","journal-title":"Med Microbiol Immunol"},{"key":"11668_CR39","doi-asserted-by":"publisher","first-page":"13836","DOI":"10.1038\/s41598-021-93266-w","volume":"11","author":"R Sharma","year":"2021","unstructured":"Sharma R, Rajput VS, Jamal S et al (2021) An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins. Sci Rep 11:13836. https:\/\/doi.org\/10.1038\/s41598-021-93266-w","journal-title":"Sci Rep"},{"key":"11668_CR40","doi-asserted-by":"publisher","first-page":"19421","DOI":"10.1038\/s41598-023-46408-1","volume":"13","author":"ER Basmenj","year":"2023","unstructured":"Basmenj ER, Arastonejad M, Mamizadeh M et al (2023) Engineering and design of promising T-cell-based multi-epitope vaccine candidates against leishmaniasis. Sci Rep 13:19421. https:\/\/doi.org\/10.1038\/s41598-023-46408-1","journal-title":"Sci Rep"},{"key":"11668_CR41","doi-asserted-by":"publisher","unstructured":"Ishwarlall TZ, Adeleke VT, Maharaj L et al (2022) Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.1023558","DOI":"10.3389\/fimmu.2022.1023558"},{"key":"11668_CR42","doi-asserted-by":"publisher","first-page":"e72745","DOI":"10.1371\/journal.pone.0072745","volume":"8","author":"Q Xin","year":"2013","unstructured":"Xin Q, Niu H, Li Z et al (2013) Subunit Vaccine Consisting of Multi-Stage Antigens Has High Protective Efficacy against Mycobacterium tuberculosis Infection in Mice. PLoS ONE 8:e72745. https:\/\/doi.org\/10.1371\/journal.pone.0072745","journal-title":"PLoS ONE"},{"key":"11668_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.coi.2016.06.007","volume":"41","author":"SG Reed","year":"2016","unstructured":"Reed SG, Hsu F-C, Carter D, Orr MT (2016) The science of vaccine adjuvants: advances in TLR4 ligand adjuvants. Curr Opin Immunol 41:85\u201390. https:\/\/doi.org\/10.1016\/j.coi.2016.06.007","journal-title":"Curr Opin Immunol"},{"key":"11668_CR44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4103\/1735-5362.268203","volume":"14","author":"M Mohammadi-Rad","year":"2019","unstructured":"Mohammadi-Rad M, Ghasemi N, Aliomrani M (2019) Evaluation of apamin effects on myelination process in C57BL\/6 mice model of multiple sclerosis. Res Pharm Sci 14:424. https:\/\/doi.org\/10.4103\/1735-5362.268203","journal-title":"Res Pharm Sci"},{"key":"11668_CR45","doi-asserted-by":"publisher","DOI":"10.18502\/ijaai.v18i3.1123","author":"MM Ghorbani","year":"2019","unstructured":"Ghorbani MM, Farazmandfar T, Nasirikenari M et al (2019) Evaluation of IL-17 Serum Level, Brain Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis C57BL\/6 Mice Model with Different Doses of Myelin Oligodendrocyte Glycoprotein. Iran J Allergy Asthma Immunol. https:\/\/doi.org\/10.18502\/ijaai.v18i3.1123","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"2","key":"11668_CR46","first-page":"171","volume":"46","author":"A Brown","year":"1982","unstructured":"Brown A, McFarlin DE, Raine CS (1982) Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest 1982 46(2):171\u2013185 PMID: 7062721","journal-title":"Lab Invest 1982"},{"key":"11668_CR47","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1084\/jem.194.5.669","volume":"194","author":"ES Huseby","year":"2001","unstructured":"Huseby ES, Liggitt D, Brabb T et al (2001) A pathogenic role for myelin-specific CD8\u2009+\u2009T cells in a model for multiple sclerosis. J Exp Med 194:669\u2013676. https:\/\/doi.org\/10.1084\/jem.194.5.669","journal-title":"J Exp Med"},{"key":"11668_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2013.04.014","volume":"260","author":"M Camara","year":"2013","unstructured":"Camara M, Beyersdorf N, Fischer HJ et al (2013) CD8\u2009+\u2009T cell help is required for efficient induction of EAE in Lewis rats. J Neuroimmunol 260:17\u201327. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.04.014","journal-title":"J Neuroimmunol"},{"key":"11668_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0165-5728(03)00210-8","volume":"141","author":"K-B Abdul-Majid","year":"2003","unstructured":"Abdul-Majid K-B, Wefer J, Stadelmann C et al (2003) Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4\u2013\/\u2013 and CD8\u2013\/\u2013 DBA\/1 mice defines qualitative roles of different T cell subsets. J Neuroimmunol 141:10\u201319. https:\/\/doi.org\/10.1016\/S0165-5728(03)00210-8","journal-title":"J Neuroimmunol"},{"key":"11668_CR50","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/nprot.2006.284","volume":"1","author":"IM Stromnes","year":"2006","unstructured":"Stromnes IM, Goverman JM (2006) Passive induction of experimental allergic encephalomyelitis. Nat Protoc 1:1952\u20131960. https:\/\/doi.org\/10.1038\/nprot.2006.284","journal-title":"Nat Protoc"},{"key":"11668_CR51","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/01.wco.0000313359.61176.15","volume":"21","author":"MK Racke","year":"2008","unstructured":"Racke MK (2008) The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies. Curr Opin Neurol 21:S9\u2013S18. https:\/\/doi.org\/10.1097\/01.wco.0000313359.61176.15","journal-title":"Curr Opin Neurol"},{"key":"11668_CR52","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/ana.21867","volume":"66","author":"K Hawker","year":"2009","unstructured":"Hawker K, O\u2019Connor P, Freedman MS et al (2009) Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol 66:460\u2013471. https:\/\/doi.org\/10.1002\/ana.21867","journal-title":"Ann Neurol"},{"key":"11668_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.msard.2017.03.013","volume":"14","author":"E Sefia","year":"2017","unstructured":"Sefia E, Pryce G, Meier U-C et al (2017) Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis. Mult Scler Relat Disord 14:46\u201350. https:\/\/doi.org\/10.1016\/j.msard.2017.03.013","journal-title":"Mult Scler Relat Disord"},{"key":"11668_CR54","doi-asserted-by":"publisher","first-page":"812","DOI":"10.2353\/ajpath.2006.050923","volume":"168","author":"T Matsushita","year":"2006","unstructured":"Matsushita T, Fujimoto M, Hasegawa M et al (2006) Inhibitory Role of CD19 in the Progression of Experimental Autoimmune Encephalomyelitis by Regulating Cytokine Response. Am J Pathol 168:812\u2013821. https:\/\/doi.org\/10.2353\/ajpath.2006.050923","journal-title":"Am J Pathol"},{"key":"11668_CR55","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","volume":"184","author":"SD Wolf","year":"1996","unstructured":"Wolf SD, Dittel BN, Hardardottir F, Janeway CA (1996) Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell\u2013deficient Mice. J Exp Med 184:2271\u20132278. https:\/\/doi.org\/10.1084\/jem.184.6.2271","journal-title":"J Exp Med"},{"key":"11668_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2004.05.001","volume":"23","author":"E Montero","year":"2004","unstructured":"Montero E, Nussbaum G, Kaye JF et al (2004) Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25\u2009+\u2009and CD8\u2009+\u2009T cells: analysis using depleting antibodies. J Autoimmun 23:1\u20137. https:\/\/doi.org\/10.1016\/j.jaut.2004.05.001","journal-title":"J Autoimmun"},{"key":"11668_CR57","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-014-0163-1","volume":"2","author":"M Koutrolos","year":"2014","unstructured":"Koutrolos M, Berer K, Kawakami N et al (2014) Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS. Acta Neuropathol Commun 2:163. https:\/\/doi.org\/10.1186\/s40478-014-0163-1","journal-title":"Acta Neuropathol Commun"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11668-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11668-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11668-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:19:21Z","timestamp":1776421161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11668-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11668"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11668-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal care and use were performed concerning the approved Iran National Research Ethics Committee (ethical approval ID: IR.SKU.REC.1398.008).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"633"}}